These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19543842)

  • 1. Role of mesenchymal stem cells in immunological rejection of organ transplantation.
    Zhang X; Jiao C; Zhao S
    Stem Cell Rev Rep; 2009 Dec; 5(4):402-9. PubMed ID: 19543842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
    De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
    Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.
    Le Blanc K; Ringdén O
    Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells overexpressing IL-35: a novel immunosuppressive strategy and therapeutic target for inducing transplant tolerance.
    Guo H; Li B; Wang W; Zhao N; Gao H
    Stem Cell Res Ther; 2018 Sep; 9(1):254. PubMed ID: 30257721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting.
    Nauta AJ; Westerhuis G; Kruisselbrink AB; Lurvink EG; Willemze R; Fibbe WE
    Blood; 2006 Sep; 108(6):2114-20. PubMed ID: 16690970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation by mesenchymal stem cells and clinical experience.
    Le Blanc K; Ringdén O
    J Intern Med; 2007 Nov; 262(5):509-25. PubMed ID: 17949362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cardiac allograft rejection in mice using interleukin-35-modified mesenchymal stem cells.
    Wang W; Zhao N; Li B; Gao H; Yan Y; Guo H
    Scand J Immunol; 2019 Apr; 89(4):e12750. PubMed ID: 30664805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?
    Introna M; Golay J
    Front Immunol; 2020; 11():609063. PubMed ID: 33362797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal cells in transplantation rejection and tolerance.
    English K; Wood KJ
    Cold Spring Harb Perspect Med; 2013 May; 3(5):a015560. PubMed ID: 23637312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells: a new strategy for immunosuppression?
    Uccelli A; Pistoia V; Moretta L
    Trends Immunol; 2007 May; 28(5):219-26. PubMed ID: 17400510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory effects of mesenchymal stem cells for the treatment of cardiac allograft rejection.
    Wu Z; Liang J; Huang W; Jiang L; Paul C; Gao X; Alam P; Kanisicak O; Xu M; Wang Y
    Exp Biol Med (Maywood); 2021 Apr; 246(7):851-860. PubMed ID: 33327780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model.
    Wan CD; Cheng R; Wang HB; Liu T
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):29-33. PubMed ID: 18234635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: a systematic review.
    Li Y; Hao J; Hu Z; Yang YG; Zhou Q; Sun L; Wu J
    Stem Cell Res Ther; 2022 Mar; 13(1):93. PubMed ID: 35246235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cells; role in tissue repair, drug discovery and immune modulation.
    English K; Mahon BP; Wood KJ
    Curr Drug Deliv; 2014; 11(5):561-71. PubMed ID: 23517624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-β-Expressing Mesenchymal Stem Cells Induce Local Tolerance in a Rat Liver Transplantation Model of Acute Rejection.
    Tang J; Yang R; Lv L; Yao A; Pu L; Yin A; Li X; Yu Y; Nyberg SL; Wang X
    Stem Cells; 2016 Nov; 34(11):2681-2692. PubMed ID: 27333806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Immunological Mechanisms of Mesenchymal Stem Cells in Allogeneic Transplantation: From the Aspect of Major Histocompatibility Complex Class I.
    Wang Y; Tian M; Wang F; Heng BC; Zhou J; Cai Z; Liu H
    Stem Cells Dev; 2019 Sep; 28(17):1141-1150. PubMed ID: 31215341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease.
    Zhao L; Chen S; Yang P; Cao H; Li L
    Stem Cell Res Ther; 2019 Jun; 10(1):182. PubMed ID: 31227011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
    Yi T; Song SU
    Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow mesenchymal stromal cells to treat complications following allogeneic stem cell transplantation.
    Battiwalla M; Barrett AJ
    Tissue Eng Part B Rev; 2014 Jun; 20(3):211-7. PubMed ID: 24410434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.